tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market
AREC
Arecor Therapeutics PLC
RESEARCH TOOLSreports

Arecor Therapeutics PLC (AREC) Stock News & Sentiment

6 Followers
Arecor boosts cash and partnerships as AT278 insulin heads toward Phase 2
Premium
Company Announcements
Arecor boosts cash and partnerships as AT278 insulin heads toward Phase 2
8h ago
Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
Premium
Company Announcements
Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
14d ago
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
Premium
Company Announcements
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
18d ago
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
Premium
Company Announcements
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
1M ago
Arecor sharpens diabetes focus as AT278 and oral peptide platform advance
Premium
Company Announcements
Arecor sharpens diabetes focus as AT278 and oral peptide platform advance
2M ago
Arecor and Sequel Med Tech to Host Virtual Panel on Future of Diabetes Treatment
Premium
Company Announcements
Arecor and Sequel Med Tech to Host Virtual Panel on Future of Diabetes Treatment
3M ago
Arecor and Sequel to Discuss Future of Insulin Delivery Systems
Premium
Company Announcements
Arecor and Sequel to Discuss Future of Insulin Delivery Systems
4M ago
More GB:AREC News >

AREC News on the Web

Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
TipRanks News
Neutral
Arecor receives $500k milestone payment from Ligand as royalty deal delivers
Proactive Investors
Bullish
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
TipRanks News
Neutral
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
TipRanks News
Neutral
Arecor targets phase II trial for AT278 in 2026 - ICYMI
Proactive Investors
Bullish
Panmure Liberum reiterates 'buy' on Arecor with 251p target after cash beat
Proactive Investors
Bullish
Arecor sharpens diabetes focus as AT278 and oral peptide platform advance
TipRanks News
Neutral
Arecor prioritises deal for phase II insulin trial as key 2026 objective
Proactive Investors
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AREC’s Media Buzz Sentiment?
Currently, no data Available
What is GB:AREC’s weekly average amount of articles?
Currently, no data Available
What is GB:AREC’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week